Grace Crawford
AstraZeneca R&D
Global Head, Clinical Quality & Compliance
Grace Crawford is an accomplished quality and compliance leader with over 27 years of experience working with international clinical trials, quality systems, regulatory compliance, and computer systems validation in the pharmaceutical, medical device, and biotech industries across GxP’s (GCP/GLP/cGMP). Her expertise is predominantly in clinical quality (GCP) and clinical quality management systems.
As the Global Head of Clinical Quality & Compliance, Grace is accountable for the development, implementation, maintenance and evolution of quality management services for Development Operations, R&D. Grace has extensive experience leading global teams accountable for quality management systems, compliance, and delivery of high quality, GCP inspection ready clinical studies. She is passionate about creating a quality mindset and raising awareness to make a positive impact to the quality culture in organizations who develop life changing medicines for patients. Before the AstraZeneca re-organization in 2019, Grace was the head of Clinical Quality & Compliance at MedImmune (the Biologics science unit within AstraZeneca) since April 2015 responsible for supporting the Clinical Biologics department. Prior to that, Grace spent over 21 years at ICON where her main focus was leading the Clinical Quality Assurance Department. She is active in industry, often chairing or presenting at conferences, and participates in Clinical Trial and Quality Assurance related forums.
